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xidant stress influences many cellular processes,
including cell growth, differentiation, and cell
death. A well-recognized link between these
processes and oxidant stress is via alterations in Ca2+
signaling. However, precisely how oxidants influence Ca2+
signaling remains unclear. Oxidant stress led to a phenotypic shift in Ca2+ mobilization from an oscillatory to a
sustained elevated pattern via calcium release–activated
calcium (CRAC)–mediated capacitive Ca2+ entry, and stromal interaction molecule 1 (STIM1)– and Orai1-deficient

cells are resistant to oxidant stress. Functionally, oxidantinduced Ca2+ entry alters mitochondrial Ca2+ handling
and bioenergetics and triggers cell death. STIM1 is
S-glutathionylated at cysteine 56 in response to oxidant
stress and evokes constitutive Ca2+ entry independent of
intracellular Ca2+ stores. These experiments reveal that
cysteine 56 is a sensor for oxidant-dependent activation
of STIM1 and demonstrate a molecular link between
oxidant stress and Ca2+ signaling via the CRAC channel.

Introduction
Calcium is a ubiquitous second messenger that is tightly controlled inside the ER, where it can be rapidly mobilized to translate receptor-mediated signaling into a cellular response. After
the initial receptor-initiated Ca2+ transient, a sustained Ca2+
influx from the extracellular milieu occurs that serves to provide
prolonged Ca2+ signals and allow ER store refilling to permit
subsequent signaling events (Berridge et al., 2003; Parekh and
Putney, 2005; Feske, 2007; Deng et al., 2009). Activation of this
capacitive Ca2+ entry by the calcium release–activated calcium
(CRAC) channel involves a complex molecular choreography.
In general, a decrease in ER luminal Ca2+ triggers Ca2+ dissociation from the ER-resident protein STIM1 (stromal interaction
molecule 1), which oligomerizes and translocates into discrete
junctions near the plasma membrane, where it binds to and
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madeshm@temple.edu
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activates members of the Orai family of CRAC channels (Luik
et al., 2006; Prakriya et al., 2006; Vig et al., 2006; Yeromin
et al., 2006; Smyth et al., 2007; Park et al., 2009; Yuan et al.,
2009). In addition to buffering Ca2+ released from ER stores,
mitochondria are also intimately involved in CRAC activation.
Through their associations with the ER (Rizzuto et al., 1998;
Csordás et al., 2006), mitochondrial Ca2+ buffering can enhance
ER Ca2+ depletion and, thus, increase CRAC activation (Gilabert
et al., 2001). Furthermore, mitochondrial Ca2+ release can enhance ER Ca2+ refilling and, thus, reduce the duration of CRAC
channel activation (Parekh, 2008). Mitochondrial Ca2+ uptake
also stimulates the production of reactive oxygen species (ROS),
which can influence both ER Ca2+ release (Bootman et al., 1992;
Huddleston et al., 2008) and reuptake by the ER (Kaplan et al.,
2003; Ihara et al., 2005). A prominent posttranslational molecular target of ROS is protein cysteine residues, which reversibly
form disulfide bridges or sulphenic acid (PSOH) or irreversibly
© 2010 Hawkins et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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produce sulphinic (PSO2H) or sulphonic acid (PSO3H) moieties
(Veal et al., 2007). Additionally, a common modification of
protein thiol is S-glutathionylation via the reversible reaction
between protein cysteine residues and glutathione (GSH;
Anathy et al., 2009; Dalle-Donne et al., 2009). However, the
specific molecular targets of oxidants that affect Ca2+ signaling
and mitochondrial function are not fully defined. In this study,
we demonstrate that, in addition to being a sensor for intra
cellular Ca2+ stores, STIM1 functions as a redox sensor to constitutively activate CRAC channels under oxidative conditions.
S-glutathionylation or C56A mutation of STIM1 positively regulates CRAC channel activation, which leads to mitochondrial
Ca2+ overload and alterations in cellular bioenergetics. Importantly, we find that GSH is a critical regulator of STIM1 signaling
during oxidative stress.

Results
Oxidative stress shapes calcium signaling
patterns by depleting cellular GSH

To investigate the role of oxidant stress in Ca2+ homeostasis,
DT40 B-lymphocytes were challenged with lipopolysaccharide
(LPS), a component of the gram-negative bacterial cell wall that
stimulates ROS production through the Toll-like receptor 4
(Asehnoune et al., 2004; Madesh et al., 2005). 1 µg/ml LPS
evoked a time-dependent increase in cellular oxidative stress
that peaked at 5 h and could be ablated by 100 µM of the antioxidant butylated hydroxyanisole (BHA; Fig. 1, A and B).
In nonchallenged B cells, IgM activation (1.5 µg/ml) of the
B cell receptor stimulates robust Ca2+ mobilization that presented
as a nonsynchronized oscillatory pattern (individual traces) and
rapidly returned to baseline (Fig. 1 C, dashed line). In contrast,
5 h of LPS treatment resulted in a phenotypic shift toward a
more elevated Ca2+ oscillation pattern after IgM addition that
remained elevated above baseline (Fig. 1 D). Restoration of an
oscillatory Ca2+ signaling pattern could be accomplished by
scavenging ROS with BHA (Fig. 1 E), indicating that the effect
of LPS on Ca2+ signaling may be mediated by oxidants. Cells
pretreated with 100 µM hydrogen peroxide (H2O2) for 20 min
also resulted in a sustained Ca2+ mobilization pattern, although
to a much higher degree than the LPS and with no oscillations
observed (Fig. 1 F). In normal cells, oxidants are effectively
scavenged through multiple endogenous antioxidants, including
superoxide dismutase, catalase, and GSH peroxidase. In addition,
the tripeptide GSH, composed of the amino acids -glutamic
acid, cysteine, and glycine, is present in millimolar quantities
in cells and serves as an important antioxidant and redox molecule. As expected, LPS led to a time-dependent depletion of the
cellular GSH pool, as determined by the GSH cross-linking
fluorophore monochlorobimane (MCB; Fig. 1 G) and by direct
measurement of cellular GSH (unpublished data). Similar
to BHA, GSH replenishment with cell-permeable GSH-ester
restored Ca2+ oscillations in LPS-challenged DT40 cells in
response to IgM (Fig. 1 H). Furthermore, GSH efflux was
unaltered in cells challenged with LPS, indicating a reduction
in intracellular GSH levels rather than loss of GSH to the extracellular milieu (unpublished data).
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Loss of GSH and sustained
cytosolic calcium alter mitochondrial
calcium handling

Under normal physiological conditions, Ca2+ is efficiently taken
up and released by mitochondria in concert with cytosolic Ca2+
levels (Fig. 2, A and B). However, the sustained elevation of
cytosolic Ca2+ concentration mediated by oxidative stress (1 µg/ml
LPS for 5 h) dramatically enhances mitochondrial Ca2+ uptake
(Fig. 2, C and D). Interestingly, elevated mitochondrial Ca2+
uptake did not occur immediately after IgM stimulation but,
rather, increased incrementally over time. This observation
indicates that during oxidative stress, mitochondrial Ca2+ uptake
is tied not to the magnitude of the cytosolic Ca2+ levels but to the
diastolic Ca2+ level between oscillatory peaks. In addition to
ROS production, LPS targets multiple signaling cascades, including the activation of NF-B and the production of various
cytokines, which may also impact the Ca2+ mobilization pattern
and must be considered. As supplementation of GSH restored
Ca2+ oscillations in LPS-challenged cells (Fig. 1 H), we chose
to focus on GSH to dissect the specific role of oxidants in modulating physiological Ca2+ signaling.
To induce oxidative stress secondary to a depletion of
GSH, DT40 cells were treated with 200 µM of the chemosensitizing agent buthionine sulfoximine (BSO; for 24 h), which
inhibits -glutamyl synthetase, the rate-limiting enzyme in
GSH synthesis (Arrick et al., 1981; Madesh et al., 1998; Diehn
et al., 2009). In contrast to untreated conditions, GSH depletion
by BSO resulted in a dramatic alteration in the Ca2+ signaling
phenotype from an oscillatory to a more sustained Ca2+ mobilization pattern after IgM addition (Fig. 2 E). Furthermore,
mitochondrial Ca2+ handling in BSO-treated cells was similar to
that of DT40 cells treated with LPS (Fig. 2, F and G) and was
proportional to the degree of GSH depletion (Fig. S1). To delineate whether the Ca2+ handling evoked by BSO was attributable
to GSH depletion (Fig. 2, H–K), we next assessed the coordination between cytosolic and mitochondrial Ca2+. In contrast to
untreated conditions (Fig. 2 L), BSO challenge triggered
sustained mitochondrial Ca2+ uptake (Fig. 2 M) that could be
reversed by GSH supplementation (Fig. 2 N). Similarly, supplementation of the antioxidants BHA or GSH-ester restored
the oscillatory mitochondrial Ca2+-handling pattern in LPStreated cells (unpublished data). These results suggest two
important points: (1) the effects of LPS on cytosolic and
mitochondrial Ca2+ handling are mediated through GSH
oxidation and (2) BSO constitutes a physiologically relevant
model in which to study the effects of oxidant stress on cellular
Ca2+ signaling.
Altered calcium signaling during
oxidant stress is mediated through
the CRAC channel

A plausible explanation for the elevation in diastolic Ca2+ between
oscillatory peaks may be an influx of Ca2+ from the extracellular
milieu via activation of the CRAC channel. The absence of extracellular Ca2+ did not affect the IgM response in wild-type (WT)
DT40 cells but stimulated robust Ca2+ entry upon the addition of
2 mM Ca2+ (Fig. 3 A). Interestingly, the BSO-mediated Ca2+

Figure 1. LPS-induced oxidative stress alters B cell receptor calcium signaling via the depletion of cellular GSH. (A) DT40 cells loaded with ROS indicator
H2DCF-DA were challenged with 1 µg/ml LPS for the indicated time period and DCF fluorescence (arbitrary units [au]) measured to assess cellular oxidants
either in the absence or presence of 100 µM of the antioxidant compound BHA. Values are representative of three independent experiments. (B) Representative images of DCF fluorescence in DT40 cells in response to 5-h LPS. DIC, differential interference contrast. (C and D) DT40 cells loaded with Fluo-4
were activated by addition of 1.5 µg/ml IgM and fluorescence recorded via confocal microscopy in control cells (C; n = 33) and after a 5-h 1 µg/ml
LPS treatment (D; n = 33). fau, fluorescence arbitrary units. Black traces are mean values of all traces, and baseline fluorescence is indicated as dashed
lines. (E) DT40 cells were pretreated with 100 µM BHA before addition of LPS (n = 33). (F) IgM evoked Ca2+ mobilization in response to direct oxidant
challenge with 100 µM H2O2 for 20 min (n = 34). (G) DT40 cells activated with either LPS or H2O2 were loaded with the GSH cross-linking fluorophore
MCB to assess reduced GSH levels via the GSH-MCB conjugate. (H) Calcium mobilization after IgM addition in DT40 cells challenged with LPS and
supplemented with 2.5 mM cell-permeable GSH-ester. IgM addition is noted by arrows. Error bars indicate mean ± SEM.

phenotype (Fig. 3 B) could be normalized by removing extracellular Ca2+ (Fig. 3 C). Like untreated cells, reintroduction of extracellular Ca2+ in BSO-treated DT40 cells resulted in CRAC activation,
which is mediated by the ER-resident protein STIM1 (Liou et al.,
2005; Roos et al., 2005). DT40 cells lacking STIM1 responded in
a similar manner to WT cells in response to IgM. However, unlike
WT cells, STIM1 knockout (KO) cells fail to demonstrate capacitive Ca2+ entry upon store depletion (Fig. 3 D; Baba et al., 2006).
Although DT40 cells express both STIM1 and STIM2, the role of
STIM2 in IgM-mediated Ca2+ entry is less clear. Surprisingly, BSO
challenge did not alter the Ca2+ mobilization pattern in STIM1deficient DT40 cells either in the presence (Fig. 3 E) or absence
(Fig. 3 F) of extracellular Ca2+, despite a near-complete depletion
of cellular GSH levels (Fig. 3 H). We next chose to determine
whether the sustained Ca2+ elevation pattern during oxidative stress
requires Orai molecules, which are the plasma membrane poreforming units of the CRAC channel. Elimination of Orai1 and -2
evoked an oscillatory Ca2+ mobilization pattern during oxidative
stress (Fig. 3 G) that appears to be Orai1 dependent (Fig. S2),

further verifying CRAC activation during BSO-induced oxidative
stress. Oxidative stress did not alter expression of the plasma membrane Ca2+ ATPases (PMCA1/4), nor did it affect cellular ATP
levels (unpublished data), further verifying activation of the CRAC
channel and not ablated extrusion of Ca2+ from the cytosol.
Depletion of GSH is associated with an elevation in ROS
production (Armstrong and Jones, 2002). However, only a slight
increase in superoxide generation (the initial radical species) was
observed in WT DT40 cells after addition of BSO, as detected by
the superoxide indicator dye dihydroethidine (HE; Fig. 3 I). Superoxide anions will undergo reduction either spontaneously or
enzymatically in the presence of superoxide dismutase to form the
stable oxidant H2O2. Unlike superoxide, BSO challenge elicited a
dramatic increase in H2O2 in WT DT40 cells, as detected by the
general ROS indicator dichlorofluorescein (DCF), indicative of a
cellular deficiency in H2O2 scavenging (Fig. 3 J). However, only
a smaller increase in H2O2 was observed in STIM1 KO DT40 cells
(Fig. 3 J), suggesting that loss of STIM1 attenuates H2O2 accumulation. Importantly, BSO-mediated ROS accumulation was not
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Figure 2. GSH depletion elicits alterations in mitochondrial calcium handling. DT40 cells were loaded with Fluo-4 and rhod-2 to simultaneously visualize
cytosolic and mitochondrial Ca2+, respectively. (A–D) Representative baseline normalized fluorescence changes (F/F0) and images of a single cell after
1.5 µg/ml IgM addition in control (A and B) and 1 µg/ml LPS-challenged (C and D; 5 h) cells. (B and D) Arrows indicate mitochondrial Ca2+ levels as
detected by rhod-2 fluorescence. (E) IgM-induced Ca2+ mobilization (Fluo-4 fluorescence arbitrary units [fau]) in individual DT40 cells exposed to 200 µM
of the GSH synthesis inhibitor BSO for 24 h (n = 37). Black trace is the mean value of all cells. (F and G) Representative baseline normalized fluorescence
changes of cytosolic (Fluo-4) and mitochondrial (rhod-2) Ca2+ and images of a single cell after 1.5 µg/ml IgM addition in 200 µM BSO-treated cells
(24 h). (G) Arrows indicate mitochondrial Ca2+ levels as detected by rhod-2 fluorescence. (H–J) Representative images of the MCB-GSH conjugate in control
(H), BSO-treated cells (I), or BSO-treated cells supplemented with 2.5 mM GSH (J) via confocal microscopy. (K) Data for different conditions were measured
from six independent experiments (n = 6). (L–N) Representative fluorescence changes of the cytosolic and mitochondrial Ca2+ changes in a single cell after
IgM addition in control (L), BSO-treated (M), and BSO + GSH-ester–challenged (N) cells of five independent experiments. IgM addition is noted by
arrowheads. Error bars indicate mean ± SEM.

altered in the presence of 30 µM of the plasma membrane NADPH
oxidase inhibitor diphenyleneiodonium (Fig. 3 K), excluding the
possibility that BSO enhanced oxidant generation via NADPH
oxidase. This important finding reveals two key features of Ca2+
signaling during oxidative stress: (1) either STIM1 or Orai1 are a
potential target of oxidative stress, and (2) activation of the CRAC
channel can be regulated by cellular redox status.
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STIM1-mediated calcium entry is required
for sustained mitochondrial calcium uptake
and aberrant bioenergetics

B cell receptor cross-linking results in coordinated cytosolic
Ca2+ mobilization and mitochondrial Ca2+ uptake in both WT
(Fig. 4 A, top) and STIM1 KO cells (Fig. 4 A, bottom). The coordination between cytosolic Ca2+ mobilization and mitochondrial

Figure 3. Loss of the CRAC channel retains the Ca2+ oscillation phenotype during oxidative stress. DT40 cells were loaded with Fluo-4 and Ca2+
mobilization recorded after IgM addition. Traces are representative of the typical cellular response. (A) Capacitive Ca2+ entry after IgM mobilization. (B) Oxidative stress alters the Ca2+ mobilization pattern in WT DT40 cells. (C) Ca2+ oscillations can be restored by removal of extracellular
Ca2+ (200 µM EGTA). (D) Ca2+ mobilization pattern in STIM1 KO DT40 cells is similar to WT but lack subsequent capacitive Ca2+ entry and is
resistant to BSO challenge both in the presence (E) and absence (F) of extracellular Ca2+. (n = 6) (G) IgM-evoked Ca2+ mobilization in Orai1/2
DKO cells are similar to STIM1 KO cells. (H)Total GSH levels as determined by luminol fluorescence in response to increasing concentrations of
BSO for 24 h. (I) Superoxide anion production in DT40 cells as detected by hydroethidine fluorescence (HE) via confocal microscopy (n = 3).
(J) Presence of the superoxide anion degradation product H2O2 via DCF fluorescence via confocal microscopy from three independent experiments
(n = 3). 1 mM H2O2 was added to BSO-challenged STIM1 KO DT40 cells for 30 min as a positive control. (K) DCF fluorescence in WT DT40 cells
in the presence of the NADPH oxidase inhibitor diphenyleneiodonium (DPI; 30 µM) after 20 h of BSO challenge. ND, nondetectable. Error bars
indicate mean ± SEM.

Ca2+ uptake can be attributed to the close physical proximity
between the mitochondria and the ER (Filippin et al., 2003).
A previous study showed that mitochondria may in fact be
tethered to the ER and that this tethering is important in both
physiological and pathological signaling (Pinton et al., 2008).
Our current findings suggest that it is Ca2+ from the extracellular milieu and the resultant elevation in diastolic Ca2+ between
oscillatory peaks (i.e., temporal Ca2+ increase) that are key
determinants of sustained mitochondrial Ca2+ uptake during
oxidative stress (Fig. S3, A and B). Although BSO challenge
dramatically altered mitochondrial Ca2+ uptake in WT cells
(Fig. 4, B and C, top), STIM1 KO cells did not exhibit
sustained mitochondrial Ca2+ uptake in response to IgM
(Fig. 4, B and C, bottom) even after reintroduction of extracellular Ca2+ (Fig. S3 C).

Sustained cytosolic Ca2+ or aberrant mitochondrial Ca2+
uptake will lead to irreversible mitochondrial dysfunction and
bioenergetic collapse (Crompton, 1999; Duchen, 2000). Consistent with our findings that BSO challenge leads to sustained
mitochondrial Ca2+ uptake (Fig. 4 C), BSO-pretreated WT DT40
cells consumed less oxygen after the sequential additions of the
mitochondrial complex I substrates malate and pyruvate and the
complex II/III substrate succinate compared with nontreated
cells (Fig. 4 D). In contrast, BSO treatment did not affect oxygen consumption in STIM1 KO DT40 cells. Ultimately, this reduction in mitochondrial bioenergetics will decrease mitochondrial
energy production and result in cell death. As reported previously (Takata et al., 1995; White et al., 2005), chronic IgM
challenge induced Ca2+-mediated cell death in WT DT40 cells
that was markedly enhanced by BSO challenge at all time points
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Figure 4. The CRAC channel is requisite for oxidative stress-induced alterations in mitochondrial Ca2+ handling, bioenergetics, and cell death. Fluo-4– and
rhod-2–loaded DT40 cells were stimulated with IgM and fluorescence changes recorded via confocal microscopy. (A) Coordinated cytosolic and mitochondrial Ca2+ levels in control DT40 cells. (B) Confocal images before and after IgM addition in BSO-pretreated WT (top) and STIM1 KO (bottom) cells.
(C) Representative single-cell traces of cytosolic and mitochondrial Ca2+ levels after IgM stimulation in BSO-treated DT40 cells. (D) Oxygen consumption in
DT40 cells in response to complex I (malate/pyruvate), complex II/III (succinate), and complex IV (TMPD/ascorbate) substrates. Traces are representative of
at least five independent experiments. (E) Sensitization of DT40 cells to 1.5 µg/ml IgM-induced cell death by BSO, as determined by nuclear incorporation of
TOTO-3. IgM was added to cells every 24 h. Values were determined by counting TOTO-3–positive cells in five independent fields at the indicated time points
via confocal microscopy (n = 3). (F) DT40 cells were sensitized with either 1 µg/ml LPS for 5 h or 200 µM BSO for 24 h and treated with 1.5 µg/ml IgM for 48
h either in the absence or presence of 2.5 mM GSH. Cell viability was assessed as the percentage of TOTO-3–negative cells in five independent fields (n = 3).
DT40 cells were simultaneously loaded with TOTO-3 and TMRE to assess plasma membrane integrity and m, respectively. (G and J) Functional mitochondria
were not observed in either LPS (G) or BSO-sensitized WT DT40 (J) cells, but TMRE fluorescence could be restored by supplementation with 2.5 mM GSH.
(H, I, K, and L) LPS and BSO had a trivial effect on either STIM1 KO (H and K) or Orai1 KO (I and L) cells. Error bars indicate mean ± SEM.
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Figure 5. Oxidative stress triggers store-independent STIM1 redistribution and CRAC activation via S-glutathionylation. COS7 cells were transfected with
WT STIM1 fused to the mCherry fluorescent construct. 36 h after transfection, STIM1 distribution was visualized via confocal microscopy. (A) STIM1 presents
as an ER-resident protein in unstimulated cells, as demonstrated by fluorescence intensity through the perinuclear region. (B and C) STIM1 redistribution to
discrete puncta near the plasma membrane is observed after either 200 µM BSO challenge for 24 h (B) or 20-min 100 µM H2O2 treatment (C). (A–C) Line
scans indicate the distribution of STIM1-mCherry before and after the treatment. (D and E) Fluo-4–loaded WT MEF cells exposed to either BSO or H2O2 exhibited capacitive calcium entry without ER calcium store depletion by 2 µM Tg (D) that was not observed in STIM1 KO MEFs (E). Traces represent the mean
fluorescence of all cells in the microscopic field. Values representing three independent experiments are displayed as a gray bar surrounding each trace.
(F and G) Addition of 2 mM Ca2+ to the extracellular buffer in control (F) and after 20-min exposure to 200 µM H2O2 (G) in DT40 STIM1 KO cells. H2O2
challenge elicited store-independent Ca2+ entry upon addition of Ca2+. STIM1-mCherry–negative cells were used as controls (n = 3). (H) Orai1 KO DT40 cells
transfected with WT STIM1 mCherry before and 2.5 min after addition of 2 µM Tg. (I) Recombinant human STIM1 protein (rhSTIM1-GST) in buffer containing 10 mM GSH was incubated with 1 mM and 0.1 mM H2O2 for 30 min and resolved under nonreducing conditions. (left) Probed with -glutathionylation
antibody (**, S-glutathionylated STIM1). (middle) Stripped membrane reprobed with -STIM1 antibody. (right) Probed with -STIM1 antibody under reducing
conditions. The arrowhead indicates native recombinant protein. Black line indicates that intervening lanes have been spliced out. (J) 200 µM 45Ca2+-binding
affinity (Luik et al., 2008; Stathopulos et al., 2008) of recombinant human STIM1 after incubation with 100 µM H2O2 for 30 min. 45Ca2+ was assessed by
liquid scintillation counting of duplicate protein filtrate samples and background corrected (n = 5). Error bars indicate mean ± SEM.

studied (Fig. 4 E). In stark contrast, STIM1 KO cells were protected from Ca2+-mediated cell death throughout the duration of
the experiment (Fig. 4 E). Supplementation of GSH reversed
IgM-induced cell death (1.5 µg/ml; 48 h) in DT40 cells challenged with either BSO or LPS (Fig. 4 F), indicating that the
mechanism for both is mediated through GSH. Both STIM1
and Orai1 KO DT40 cells treated with either BSO or LPS were
resistant to IgM-induced cell death, as determined by nuclear
incorporation of TOTO-3 (Fig. 4 F). Mechanistically, TOTO-3
staining was preceded by the loss of the mitochondrial membrane potential (m) both in LPS (Fig. 4 G)- and BSO-treated
(Fig. 4 J) cells, indicating a loss of mitochondrial function before
cell death (Fig. 4, G and J, black dots). GSH supplementation

restored m in WT DT40 cells (Fig. 4, G and J, red dots). Neither LPS nor BSO alone altered m in WT cells (unpublished
data). Interestingly, m was unaltered in STIM1 and Orai1
KO cells (Fig. 4, H, I, K, and L). These findings clearly establish that sustained mitochondrial Ca2+ uptake, mitochondrial
dysfunction, and cell death during oxidative stress are dependent on GSH bioavailability and CRAC-mediated Ca2+ entry.
Oxidative stress stimulates STIM1
puncta formation and store-independent
calcium entry

Upon store depletion, STIM1 oligomerizes, redistributes, and
binds to the plasma membrane–localized protein Orai1/CRACM1
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Figure 6. Identification of cysteine 56 as the site for S-glutathionylation in response to oxidants. (A) Sequence alignment of STIM1 demonstrates evolutionary conservation of cysteine residues at positions 49 and 56. (B) Schematic for STIM1 mutant constructs. (C) Coomassie staining of a truncated N-terminal
STIM1 fragment (amino acids 23–213) exposed to 100 mM H2O2 for 30 min and run on a 4–12% Bis-Tris gel under nonreducing conditions (DTT).
No shift in protein mobility was detected, indicating that oxidant stress did not facilitate the formation of disulfide bonds in the STIM1 protein. (D) COS7
cell lysates from STIM1-transfected cells were incubated with 200 µM H2O2 for 30 min and immunoprecipitated (IP) with an -STIM1 antibody. Immuno
precipitated STIM1 was resolved by electrophoresis under nonreducing conditions (DTT) and probed for S-glutathionylation using a small peptide antibody
against GSH. Nontreated samples were also resolved under reducing conditions (+DTT) and probed for STIM1 for input control. A truncated N-terminal
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to form the CRAC channel and trigger Ca2+ entry and refilling
of the ER stores (Prakriya et al., 2006). As our work demonstrates that oxidative stress enhances Ca2+ influx, we hypothesized that the STIM1 cellular distribution may be altered during
oxidative stress. Because STIM1 is a dynamic protein, we chose
to overexpress fluorescently tagged (mCherry) STIM1 in COS-7
cells to visualize its localization in live cells. In unstimulated
COS-7 cells, STIM1 presents primarily as an ER-resident protein (Fig. 5 A). However, both 100 µM BSO challenge (Fig. 5 B)
and H2O2 (20 min; Fig. 5 C) triggered redistribution from the
ER to sites near the plasma membrane, demonstrating that oxidant stress promotes STIM1 oligomerization and may, perhaps,
trigger CRAC activation. Addition of Ca2+ to the extracellular
milieu evoked robust Ca2+ entry in BSO- and H2O2-treated, but
not untreated, mouse embryonic fibroblasts (MEFs; Fig. 5 D).
In contrast, Ca2+ entry was not observed in STIM1 KO MEFs,
excluding the possibility that BSO or H2O2 may facilitate Ca2+
entry through other mechanisms other than the CRAC channel
(Fig. 5 E). Although it is possible that oxidant stress may deplete ER Ca2+, addition of the SERCA (sarco-ER Ca2+ ATPase)
of Ca inhibitor thapsigargin (Tg) resulted in the passive depletion of ER Ca2+ and subsequent capacitive Ca2+ entry upon re
introduction of extracellular Ca2+ (unpublished data), indicating
intact ER Ca2+ stores and normal CRAC channel function. Furthermore, DT40 cells under 100 µM H2O2 challenge (30 min)
exhibited similar levels of ER Ca2+ as the control (unpublished
data). Although STIM1 overexpression by itself did not induce
constitutive Ca2+ entry (Fig. 5 F), short-term exposure to 200 µM
H2O2 triggered capacitive Ca2+ entry without the need for ER
store depletion by Tg (Fig. 5 G) in DT40 STIM1 KO cells overexpressing STIM1. In these experiments, DT40 cells were incubated with H2O2 for 20 min in Ca2+-containing conditions and
transferred to the experimental buffer lacking Ca2+. Interestingly, because of this experimental methodology, we observed
higher basal cytosolic Ca2+ levels in STIM1-positive cells versus STIM1-negative neighboring cells (Fig. 5 G), indicating
the rapid activation of oxidant-triggered, STIM1-mediated
Ca2+ entry. Nontransfected neighboring cells did not exhibit storeindependent Ca2+ entry, further supporting that the H2O2 effect
did not reflect oxidant-mediated ER Ca2+ depletion but, rather,
required the expression of STIM1. Furthermore, BSO challenge
in Orai1 KO cells did not result in CRAC activation (Fig. S4);
however, the formation of STIM1 clusters remained un
affected (Fig. 5 H), revealing that STIM1, not Orai1, may be a
target for cellular oxidants. Further investigation revealed that
STIM1 puncta formation was dependent on the ER-luminal
portion of the protein (Fig. S5).
A prominent molecular target of H2O2 is the reactive thiol
group of the amino acid cysteine. Protein thiol groups react
with H2O2 to yield sulfenic acid (R-SOH), which undergoes

nucleophilic attack by RSH, resulting in disulfide formation
(RSSR). Under oxidative conditions, GSSG can react with
reactive thiol groups on proteins in this fashion in a process
known as S-glutathionylation, which results in protein-specific
functional changes. Under BSO-induced stress, S-glutathionylation is effectively an irreversible process because of the lack of
free GSH needed to remove GSH via glutaredoxins. To test
whether STIM1 is a target of S-glutathionylation, 0.3 µg recombinant human STIM1 was subjected to H2O2 in the presence of
10 mM GSH in a cell-free system. H2O2 challenge resulted in a
strong S-glutathionylation signature, as detected by Western
blotting (Fig. 5 I). Furthermore, S-glutathionylation was associated with a marked shift in molecular mass, implying that
S-glutathionylation of STIM1 results in oligomer formation, a
key step in CRAC activation. Addition of the reducing agent
DTT normalized protein mobility in response to H2O2, indicating the reversibility of STIM1 S-glutathionylation. Mechanistically, H2O2-mediated S-glutathionylation decreases the Ca2+binding affinity of STIM1 (Fig. 5 J), thereby decoupling ER
Ca2+ levels from CRAC activation.
Identification of cysteine 56 as the site for
STIM1 S-glutathionylation

STIM1 is an evolutionarily conserved protein that is composed
of a single transmembrane domain with a Ca2+-binding domain
(EF hand) and a sterile -motif at the N terminus and a coiled-coil
region and proline-rich C terminus (Baba et al., 2006). Analysis
of the formation of active STIM1–Orai1 complexes revealed
that CRAC formation is dependent on the STIM1 C termi
nus, which is activated in response to ER Ca2+ depletion (Park
et al., 2009; Yuan et al., 2009). Although considerable hetero
geneity exists between species, a defining feature of STIM1
is the presence of two highly conserved cysteine residues in the
N-terminal region, which is located within the ER lumen near
the EF hand (Fig. 6 A). Deletion of these residues along with the
EF hand resulted in constitutive store-independent Ca2+ entry
(Zhang et al., 2005). As cysteine residues are important targets
for oxidants via either direct modification (e.g., intramolecular
disulfide bonds or R-SOH formation) or S-glutathionylation,
we therefore chose to investigate the role of these two conserved
cysteine residues in STIM1-mediated Ca2+ entry (Fig. 6 B).
Exposure of the STIM1 N-terminal region (amino acids 23–312),
containing the EF hand and cysteine residues 49 and 56, to 100 µM
H2O2 for 30 min did not alter protein mobility under nonreducing
conditions (i.e., without DTT), suggesting that oxidant stress
did not directly modify STIM1 (Fig. 6 C). Because STIM1 can
be directly S-glutathionylated in the presence of oxidants
(Fig. 5 I), we next sought to identify which reactive cysteine
serves as molecular target of oxidants in intact cells. Although
no S-glutathionylation signature was detected under normal

STIM1 fragment (amino acids 23–312) was subjected to tryptic digestion and assessed for S-glutathionylation at cysteine 56 by mass spectrometry.
*, S-glutathionylation of STIM1; **, higher molecular mass STIM1 after H2O2 treatment. (E) Sequence of recombinant STIM1 fragment. Red indicates sequences not detected by MALDI time of flight. Blue indicates that the sequence contains cysteine 56. The green box indicates that the presence of GSH in
this fragment can only be associated with the cysteine residue at position 56. (F) 30-min exposure of recombinant STIM1 protein to 100 µM H2O2 resulted
in the formation of a mass spectra at a calculated mass of 2,522.0 ± 0.4 kD that was absent in the nontreated sample, corresponding to an increase of
306 to the predicted mass of the blue peptide fragment in D (2,216.102 kD). The molecular mass of reduced GSH is 307 D.

Glutathionylated STIM1 in mitochondrial homeostasis • Hawkins et al.

399

conditions, significant S-glutathionylation in both STIM1 and
the SM1 mutant, but not the SM2 mutant, were observed after
H2O2 challenge (Fig. 6 D), revealing the cysteine at position 56
as exquisitely sensitive to oxidant stress. As in our cell-free conditions, S-glutathionylation also resulted in the formation of
a large molecular mass protein under nonreducing conditions
(Fig. 6 D, **). Importantly, the mechanism is reversible, as resolving these proteins under reducing conditions revealed no
S-glutathionylation in any of the STIM1 mutants (unpublished
data). To conclusively demonstrate the identity of the glutathionylated residues on STIM1, the recombinant N-terminal region
(amino acids 23–312) of STIM1 was exposed to 100 µM H2O2
in the presence of 10 mM GSH. Tryptic digestion resulted in
the separation of the cysteine residues at positions 49 and 56
into two distinct peptide fragments, with position 56 within
the fragment containing amino acids 181–199 and a mass of
2,216.102 kD (Fig. 6 E, blue). In the H2O2-treated, but not the
control sample, a mass spectra was found at 2,522.0 ± 0.4 kD
(Fig. 6 F). This corresponds to the predicted fragment mass of
2,216.102 + 306 kD, which is the deprotonated molecular mass
of GSH. Because GSH can only react with free thiol groups, the
presence of GSH in this fragment can only be associated with the
cysteine residue at position 56 (Fig. 6 E, green box). Together
with protein mobility and immunoblotting, the detection of
GSH clearly identifies that the two cysteine residues in the
N-terminal region of STIM1 are not directly modified by oxidants, but rather, cysteine 56 is a site for S-glutathionylation in
the presence of oxidants.
Modification of STIM1 at cysteine 56
evokes constitutive CRAC activity

A fundamental question is whether cysteine 56 is crucial for
CRAC channel activation. To test this, Ca2+ entry was measured
in STIM1 KO DT40 cells after the reexpression of mCherrytagged WT, SM2, and double-mutant (DM) STIM1 variants.
Surprisingly, similar to BSO and H2O2 treatment, expression of
STIM1 mutants (SM2 and DM) in STIM1 KO DT40 cells resulted in constitutive Ca2+ entry, as detected by confocal microscopy (Fig. 7, A and B). Reconstitution of WT STIM1 in
STIM1 KO DT40 cells also rescued BSO-induced constitutive
Ca2+ entry (Fig. 7, A and B), whereas nontransfected neighboring cells did not exhibit an increase in Ca2+ fluorescence (unpublished data). In addition, introduction of the SM2 mutant
increased ROS production in DT40 STIM1 KO cells to similar
levels as BSO challenge (unpublished data). Moreover, in
HEK293T cells, SM2 or DM mutation resulted in a substantial
redistribution of STIM1 toward the plasma membrane, where it
colocalized with Orai1 (Fig. 7 C). Functionally, overexpression
of SM2 resulted in the formation of puncta (Fig. 7 C) and a constitutive CRAC current that was independent of the ER Ca2+
stores (Fig. 7, D–F).

Discussion
Molecular identification of STIM1 as the ER Ca2+ sensor in
CRAC activation has greatly aided our understanding of Ca2+
signaling. However, a key question regarding how STIM1 is


400

JCB • VOLUME 190 • NUMBER 3 • 2010

controlled remains unanswered; namely, what physiological
cues can modulate STIM1-mediated Ca2+ entry. Oxidative stress
has long been implicated in Ca2+ dysregulation. In particular,
lymphocytes respond to oxidants by an increase in basal Ca2+
levels (Howe et al., 2004). Although it is possible that oxidants
may affect ER Ca2+ release or inhibit reuptake by SERCA
pumps, the present findings suggest that oxidants directly decrease STIM1 Ca2+-binding affinity via S-glutathionylation at
cysteine 56, facilitating constitutive Ca2+ entry and elevating
basal cytosolic Ca2+ levels. This is supported by our findings
that STIM1 KO DT40 cells are immune to LPS- and BSOinduced oxidative stress and that reintroduction of STIM1 into
STIM1 KO DT40 lymphocyte cells markedly elevated basal
cytosolic Ca2+ levels when exposed to oxidant stress compared
with nontransfected neighboring cells (Fig. 5 G). Furthermore,
genetic removal of either STIM1 (Fig. 5 E) or Orai1 (Fig. S4)
eliminated constitutive CRAC activation in response to oxidant
challenge. Therefore, these data are the first to definitively link
Ca2+ regulation and cellular redox status and establish STIM1
as an important sensor for oxidative stress.
LPS is a common inflammatory signal inducer that initiates ROS production through Toll-like receptor 4 (Park et al.,
2004), leading to extensive proliferation and differentiation in
leukocytes (Coutinho et al., 1974). In contrast, B cell receptor
antigen cross-linking can trigger several outcomes, including
activation, proliferation, or death, depending on the stage of B cell
development (Khan, 2009). However, costimulation by both
LPS and antigens acts synergistically to sensitize B cells (Minguet
et al., 2008), possibly allowing the immune system to focus B cell
maturation only on antigen-presenting B cells (Ruprecht and
Lanzavecchia, 2006). After activation, unregulated lymphocyte
proliferation would exacerbate the immune response and could
lead to the development of autoimmune diseases such as rheumatoid arthritis (Busconi et al., 2007). Based on our findings,
it is possible that chronic mitochondrial ROS generation serves
to limit lymphocyte activation through a gradual reduction in
mitochondrial energy production, thus acting as a stop signal
that limits the immune response. Costimulation of inflammatory molecules that generate ROS and mobilize Ca2+ exist in
several different tissues aside from lymphocytes, including LPS
and CD14 in dendritic cells (Zanoni et al., 2009) and TNF and
leukotriene B4 in endothelial cells (Qiu et al., 2006). Therefore,
we postulate that enhancement of CRAC by S-glutathionylation
activation is the mechanism whereby ROS and Ca2+ synergistically modulate inflammation. Because elevated basal Ca2+ was
also noted in other cell types, including HEK293, COS-7
(unpublished data), and the ubiquitous expression of STIM1,
oxidant-regulated, STIM1-mediated Ca2+ entry may be an important physiological process in many tissues. S-glutathionylation of STIM1 correlated with an approximately threefold
decrease in GSH from normal cellular levels (Fig. 3 H).
The defining step in CRAC activation is STIM1 oligomerization that follows Ca2+ dissociation from the EF hand region
(Smyth et al., 2008). Structurally, it is believed that Ca2+ dissociation disrupts interactions between the EF hand and sterile
-motif domains and results in STIM1 destabilization and partial unfolding, which facilitates oligomerization of STIM1 and

Figure 7. Constitutive activation of STIM1 by point mutation of cysteine 56. (A) DT40 STIM1 KO cells transfected with STIM1-mCherry mutant constructs
were loaded with Fluo-4 and fluorescence changes recorded after addition of Ca2+ to the extracellular milieu. SM2 and DM constructs demonstrated storeindependent Ca2+ entry versus WT STIM1 and DsRed (control) constructs. WT STIM1 pretreated with BSO exhibited constitutive Ca2+ entry. Traces represent
mean fluorescence values. (B) Mean fluorescence intensity within 90 s of Ca2+ addition in at least three independent experiments. (C) HEK293T cells transfected with both STIM1-mCherry and Orai1-GFP. SM2 and DM constructs demonstrate STIM1 redistribution and Orai1 colocalization. Conventional whole
cell recordings were performed in HEK293 CFP-Orai1 stable cells transfected with control, WT, or SM2 STIM1-mCherry constructs. (D) Typical time course
of CRAC current after addition and removal of 10 mM calcium in HEK293 Orai1-CFP cells with cytosolic Ca2+ levels clamped at rest. (E) Representative
current–voltage relationship of the CRAC current at maximal activation in 10 mM Ca2+. (F) Quantitation of peak CRAC current shown in E at 100 mV
(n = 8 cells). Error bars indicate mean ± SEM.
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CRAC activation (Stathopulos et al., 2008). Because of their
proximity to the EF hand, the highly conserved cysteine residues at positions 49 and 56 were considered potential target
sites of oxidants via intra- or intermolecular disulfide bonds or
through S-glutathionylation. Initially, we hypothesized that replacing the cysteine residues with the nonreactive amino acid
alanine would ablate oxidant-induced constitutive Ca2+ entry.
Surprisingly, cells transfected with mutant STIM1 constructs
displayed dramatic redistribution of STIM1 into discrete puncta
near the plasma membrane and higher basal Ca2+ levels and
CRAC activation, which is indicative of STIM1 oligomerization. Although unexpected, this finding is consistent with a previous study in which point mutation of single amino acids
within the EF hand led to CRAC activation (Zhang et al., 2005).
Likely, by virtue of its close proximity to the EF hand region of
STIM1 (10 amino acids), either mutation or S-glutathionylation
of cysteine 56 alters protein confirmation enough to decrease
Ca2+-binding affinity and activate the protein. Of these mutants,
we identified that WT STIM1 and the SM1 mutation (C49A)
mutants formed large molecular mass structures in the presence
of H2O2 under nonreducing conditions (Fig. 6 D, **). Furthermore, this STIM1 S-glutathionylation appears to be a nonenzymatic process, as GSH was detected both by immunoblotting
(Fig. 5 I) and mass spectrometry (Fig. 6 F) in a cell-free system.
Reducing the samples with DTT removed GSH from the cys
teine at position 56 (unpublished data) and disrupted the for
mation of these large molecular mass oligomers (Fig. 5 I),
effectively demonstrating the reversibility of this mechanism.
Functionally, STIM1 S-glutathionylation serves to reduce the
Ca2+-binding affinity of the EF hand region (Fig. 5 J), effectively activating STIM1 independent of ER calcium levels.
A recent study demonstrated that STIM1 oligomerization is the
switch that links ER store depletion and CRAC activation (Luik
et al., 2008). However, the study used an artificial system to
oligomerize STIM1 independent of ER Ca2+ levels. Our experiments are the first to demonstrate reversible STIM1 oligomerization independent of ER Ca2+ stores using a physiological
model of chronic autocrine-derived oxidant stress. In contrast,
acute challenge with H2O2 (paracrine) triggered inactivation
of Orai1-dependent CRAC activity (Bogeski et al., 2010).
Although contradictory to this finding, we postulate that our
model of chronic autocrine oxidant production serves a different
cellular response than that of an acute oxidant challenge.
In contrast to transient Ca2+ elevations, which restrict the
actions of Ca2+ to specific, high affinity targets, chronic elevations in cytosolic Ca2+ extend the duration for Ca2+ binding
(Boulware and Marchant, 2008). Thus, sustained Ca2+ elevations can influence additional cellular processes such as transcription (Dolmetsch et al., 1997) and enzyme activation (Leslie,
1997). Our data suggests that sustained Ca2+ elevations also
govern mitochondrial Ca2+ handling. Elevated cytosolic Ca2+
triggers mitochondrial Ca2+ uptake by the Ca2+ uniporter (Kirichok
et al., 2004), which is then inactivated by sustained Ca2+ levels
(Parekh, 2008). Both LPS- and BSO-induced oxidative stress
elicited mitochondrial Ca2+ uptake in a step-wise manner (Fig. 1 A;
Fig. 2, F and M; Fig. 4 C; Fig. S1; and Fig. S3). The magnitude of
each of these step-wise increases was similar to physiological Ca2+
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transients seen in nonstressed mitochondria (Fig. 2, A and L;
Fig. 4 A; and Fig. S1), which is indicative of intact uniporter
function. These results suggest that chronic STIM1-mediated
elevation in cytosolic Ca2+ is likely sufficient to sensitize the
mitochondria either by inhibiting the inactivation phase of the
uniporter or altering mitochondrial Ca2+ extrusion. In addition
to STIM1, S-glutathionylation of mitochondrial proteins can
also occur and has been linked to both cell death and survival.
Reversible glutathionylation of complex I increases mitochondrial superoxide formation that leads to oxidative damage and
cell death (Taylor et al., 2003). Furthermore, deglutathionylation of complex II decreases mitochondrial electron transfer
activity during myocardial ischemia and reperfusion injury
(Chen et al., 2007). In contrast, S-glutathionylation of adenine
nucleotide translocase via carbon monoxide prevents loss
of mitochondrial membrane permeabilization and apoptosis
(Queiroga et al., 2010). In this study, we demonstrate that the
S-glutathionylation of the ER-resident protein STIM1 affects
the mitochondrial homeostasis via CRAC activation and an
elevation in cytosolic Ca2+.
In conclusion, these findings demonstrate a relationship
between oxidative stress and STIM1-mediated Ca2+ entry. By
reversibly targeting the highly conserved cysteine 56 residue
near the EF hand, oxidant-induced S-glutathionylation decreases
Ca2+ binding, triggering STIM1 oligomerization and CRAC activation independent of ER Ca2+ stores. Constitutive activation
of the CRAC channel facilitates an increase in Ca2+ levels both
at rest and after cellular activation (i.e., increases in diastolic
Ca2+). This sustained Ca2+ increase enhances mitochondrial Ca2+
loading and influences mitochondrial function, which over time
can trigger cell death. Because of the widespread tissue expression of STIM1, this mechanism is likely to be involved in many
different cell types and may play an important role in both physiological and pathological signaling by ROS.

Materials and methods
Cell culture
WT (DT40 WT), STIM1 KO (DT40 STIM1 KO), and Orai KO B cell lines
were cultured in RPMI 1640 supplemented with 10% FCS, 1% chicken
serum, and antibiotics. HEK293T, COS7, and MEF (WT and STIM1 KO) cell
lines were cultured in DME supplemented with 10% FCS and antibiotics.
To induce oxidative stress, LPS (Sigma-Aldrich) or BSO (Sigma-Aldrich)
was added at the indicated concentration 5 and 24 h before experimen
tation, respectively. BHA (Sigma-Aldrich) was added to cells 1 h before
LPS challenge.
Measurement of cytosolic and mitochondrial Ca2+ concentration ([Ca2+]c
and [Ca2+]m)
DT40 cells were affixed to Cell-Tak–coated (BD) 25-mm glass coverslips
and loaded with 5 µM Fluo-4/AM in extracellular medium (ECM) as described previously (Madesh et al., 2005). For simultaneous measurement
of [Ca2+]c and mitochondrial Ca2+ uptake, cells were loaded with 2 µM
rhod-2/AM (Invitrogen) and 5 µM Fluo-4/AM in ECM followed by an additional 10-min incubation in a dye-free medium. Coverslips were placed
in a chamber and mounted in an open perfusion microincubator (PDMI-2;
Harvard Apparatus) and maintained at 37°C on an inverted microscope
(TE300 [Nikon] and Axio Observer [Carl Zeiss, Inc.]). 5 µg/ml mouse
anti–chicken IgM (SouthernBiotech) was added after 1 min of baseline recording, and images were recorded every 3 s using a confocal imaging system (Radiance 2000; Bio-Rad Laboratories) or a laser-scanning confocal
system (510 Meta; Carl Zeiss, Inc.) equipped with an Argon ion laser source
at 488- and 568-nm excitation using a 60× oil objective. Images were

acquired using either Lasersharp or ZEN 2008 software (Carl Zeiss, Inc).
Images were analyzed and quantitated using ImageJ (National Institutes of
Health) and a custom-made software (Spectralyzer). To assess Ca2+ entry,
Ca2+-free ECM was used in conjunction with 0.5 mM EGTA. 2 mM Ca2+
was added as indicated.
GSH measurement
GSH concentration was assessed via the reaction of GSH with Ellman’s reagent using a spectrophotometer according to the manufacturer’s protocol
(Cayman Chemical). GSH was measured in intact cells using the fluorescent compound MCB (Invitrogen). In brief, 10 µM MCB was added directly
to DT40 cells in complete medium and allowed to incubate at 40°C for
20 min. MCB will enter cells and bind to GSH to form the fluorescent adduct GSH-MCB. MCB will not react with oxidized GSSG. After loading,
cells were washed, resuspended in HBSS, and fluorescence recorded using
a confocal system (510 Meta) with excitation at 488 nm.
Detection of ROS
WT and STIM1 KO DT40 cells were challenged with 200 µM BSO. 24 h
after BSO addition, cells were stained with 10 µM HE or 5 µM 5-(and-6)chloromethyl-27-dichlorodihydrofluorescein diacetate acetyl ester (CMH2DCF-DA or DCF) to detect superoxide anion and H2O2, respectively.
Cells were washed, spun, and placed on the stage of a confocal imaging
system (510 Meta). Excitation was 561 nm and 488 nm for HE and DCF,
respectively. Images were analyzed using ImageJ software. For a positive
control, BSO-treated DT40 STIM1 KO cells were incubated with 1 mM
H2O2 for 30 min during DCF staining.
STIM1 S-glutathionylation
Recombinant human GST-tagged STIM1 was purchased from Abnova.
0.3 mg protein (in buffer containing 10 mM GSH) was incubated with either
1.0 or 0.1 mM H2O2 for 30 min at 23°C. Samples were resolved on a
4–12% Bis-Tris gel in the absence of reducing agents and probed with
-GSH antibody (1:1,000; Virogen). The membrane was then stripped
and probed with -STIM1 (1:500; BD).
45

Ca2+-binding experiments
Calcium binding to STIM1 was assessed as the protein-bound radioactivity
retained after ultrafiltration procedure as described previously with minor
modification (Ames et al., 2000). In brief, full-length GST-tagged STIM1 recombinant protein (Abnova) was subjected to the S-glutathionylation re
action as described in the previous paragraph. Both control and 0.1 mM
H2O2–treated WT recombinant STIM1 (600 ng/sample) protein was incubated with 0.2 mM 45CaCl2 in phosphate-buffered saline, pH 7.4, for
30 min at room temperature. After washing twice, the radioactivity in the
protein-containing solution was determined by liquid scintillation counting.
Mitochondrial oxygen consumption
Oxygen consumption was measured using MitoCell (MT200; Strathkelvin
Instruments). In brief, 107 DT40 cells were washed in ECM, pelleted, resuspended, permeabilized in 110 µl intracellular medium containing 40 µg/ml
digitonin, and placed into the MT200 chamber at 40°C under constant
stirring. The oxygen electrode was calibrated using air-saturated ddH2O
and the oxygen chelator Na2SO3 for 21% and 0% dissolved oxygen, respectively. After 30-s equilibration, the following additions were added in
the following order: 5 mM malate/pyruvate, 100 nM rotenone, 5 mM succinate, 50 nM antimycin A, 5 mM ascorbate/0.25 mM TMPD (tetramethylp-phenylenediamine), and 1 µM CCCP. Representative traces are displayed
and are indicative of three independent experiments.
Cell viability
Untreated and 200 µM BSO–treated cells were activated with 1.5 µg/ml
IgM every 24 h, and cell viability was determined via nuclear TOTO-3
(Invitrogen) incorporation. In brief, cells were pelleted, stained with TOTO-3
(1:1,400), and imaged at 633/660-nm excitation/emission using a
confocal imaging system (510 Meta). TOTO-3 is normally membrane impermeable and only becomes incorporated into the nucleus when the
plasma membrane is compromised. In some experiments, untreated cells
and those treated with either LPS or BSO were simultaneously loaded with
TOTO-3 and the mitochondrial membrane potential indicator tetramethylrhodamine, ethyl ester (TMRE) to determine cell viability and mitochondrial
function, respectively. Cells were challenged with BSO as above and
1 µg/ml LPS every 24 h. Samples were loaded with TOTO-3 and 100 nM
TMRE for 15 min and imaged at 633/660-nm and 561/590-nm excitation/emission, respectively. Images were collected from five independent
microscopic fields for three independent experiments, and simultaneous

fluorescence was measured using ImageJ. Values indicate mean ± SEM
(n = 3). Simultaneous fluorescence scatter plots for at least 600 data points
are represented for both TOTO-3 and TMRE.
STIM1-mCherry mutation and cell transformation
Substitution of alanine for cysteine at positions 49 and 56 in STIM1mCherry constructs was performed using a site-directed mutagenesis kit
(Quikchange; QIAGEN). COS7 and HEK293T cell lines were transfected
using TransIT reagent according to manufacturer’s protocol (Mirus Bio LLC).
DT40 cells were transfected via electroporation of 0.5 × 106 cells in 0.5 ml
RPMI using a gene pulsar apparatus (340 V and 950 microfarads; Bio-Rad
Laboratories). STIM1 puncta were assessed using the WT STIM1-mCherry
construct in Orai1 KO DT40 cells. In brief, cells transfected via electroporation were fixed on Cell-Tak–coated coverslips and imaged at 561 nm both
before and after Tg addition in the presence or absence of BSO. YFPSTIM1K (1–666), GFP-SOAR-LQ347/348AA, and mCherry-Orai1 were
N-terminally labeled and were provided by S. Muallem (University of Texas
Southwestern Medical Center, Dallas, TX).
Mass spectrometry
Recombinant N-terminal portion of the STIM1 protein tagged with
0.3 µg calmodulin (Novus Biologicals) was incubated with 100 µM
H2O2 in the presence of 10 mM GSH for 30 min as previously described (Aracena-Parks et al., 2006). Control conditions were incubated
with 10 mM GSH without H2O2. Proteins were precipitated in acetone
from the buffer solution. Two enzymes were used for the protein digestion: sequencing grade modified trypsin (Promega) and endoproteinase
Asp-N (Roche) at 35°C overnight. For matrix-assisted laser desorption/
ionization (MALDI) time of flight peptide mass fingerprinting, 0.3 µl digested peptides and 0.3 µl matrix (CHCA; Fluka) were spotted onto a
MALDI target plate and allowed to dry. Mass spectra were acquired
with a mass spectrometer (Reflex IV; Bruker Daltonics) between 500 and
5,000 m/z in reflectron mode and peptide peaks internally calibrated
using trypsin autolysis peaks.
Immunoblotting
Protein lysates were prepared from COS7 cells transfected with STIM1
WT and mutant plasmids 36 h after transfection. Samples were immunoprecipitated with an -STIM1 antibody and divided into two aliquots: one
prepared with loading buffers lacking DTT (nonreducing conditions), and
one prepared in DTT-containing loading buffers. Proteins were resolved
on a 4–12% Bis-Tris gel (Invitrogen) and blotted with -STIM1 (BD) and
-GSH (Virogen) antibodies for reducing and nonreducing conditions,
respectively. After initial blotting, the -STIM1 was stripped and reprobed
with -GSH to determine the S-glutathionylation reversibility. Plasma
membrane Ca2+ ATPase levels in DT40 cells were assessed by immuno
blotting. Anti-PMCA1/4 was purchased from Santa Cruz Biotechnology,
Inc. (PMCA1/4).
Electrophysiology
In brief, linear voltage ramps of 50-ms duration spanning the voltage range
of 100 to 100 mV were delivered from a holding potential of 0 mV at a
rate of 0.5 Hz. The currents were filtered at 6 kHz and sampled at 10–50-µs
intervals. We used automatic capacitive and series resistance compensation of the amplifier (EPC-10; HEKA). The intracellular solution contained
145 mM CsGlu, 10 mM Hepes, 10 mM EGTA, 8 mM NaCl, 6 mM MgCl2,
2 mM Mg-ATP (total 8 mM Mg2+), and 3 mM CaCl2, pH 7.2. 8 mM Mg2+
and ATP were used to inhibit TRPM7. According to WEBMAXCLITE (http://
www.stanford.edu/~cpatton/webmaxc/webmaxclite115.htm), the free Ca2+
concentration was 100 nM. The extracellular solutions contained 145 mM
NaCl, 10 mM CaCl2, 10 mM CsCl, 2 mM MgCl2, 2.8 mM KCl, 10 mM
Hepes, and 10 mM glucose, pH 7.4. For Ca2+-free solution, 10 mM CaCl2
was replaced by 10 mM MgCl2.
Online supplemental material
Fig. S1 shows the dose-dependent alterations in IgM-induced calcium
mobilization and mitochondrial calcium uptake in response to increasing
concentrations of BSO. Fig. S2 demonstrates that Orai1 is requisite for the
phenotypic alteration in calcium mobilization observed during oxidative
stress. Fig. S3 shows the restoration of transient mitochondrial calcium
uptake by elimination of capacitative calcium entry. Fig. S4 shows that
Orai1 KO cells do not exhibit calcium entry in response to BSO. Fig. S5
illustrates that puncta formation under oxidant stress is dependent on the
STIM1 N-terminal region. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.201004152/DC1.
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